Standing, J., Buggiotti, L., Guerra-Assuncao, J., Woodall, M., Ellis, S., Agyeman, A., Miller, C., Okechukwu, M., Kirkpatrick, E., Jacobs, A., Williams, C., Roy, S., Martin-Bernal, L., Williams, R., Smith, C., Sanderson, T., Ashford, F., Emmanuel, B., Afzal, Z., Sheilds, A., Richter, A., Dorward, J., Gbinigie, O., Lown, M., Francis, N., Jani, B., Richards, D., Rahman, N., Yu, L., Thomas, N., Hart, N., Evans, P., Andersson, M., Hayward, G., Hood, K., Nguyen-Van-Tam, J., Little, P., Hobbs, F., Khoo, S., Butler, C., Lowe, D., Breuer, J. & van Hecke, O. 2024, 'Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients', Nature Communications, 15, article no: 1652. https://doi.org/10.1038/s41467-024-45641-0